Home › Funds › VALLEY WEALTH MANAGERS, INC. › VRTX

VALLEY WEALTH MANAGERS, INC. position in VRTX

VERTEX PHARMACEUTICALS INC · Health Care

VALLEY WEALTH MANAGERS, INC. reported holding 51,753 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$27.1M, representing 1.54% of its reported portfolio and ranking #24 among its reported holdings. VALLEY WEALTH MANAGERS, INC. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)51.75K sh
Reported value held$27.06M
Portfolio Weight1.54%
First reportedQ3 2023
Last changeAdd
Updated2026-10-09

Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR

How VALLEY WEALTH MANAGERS, INC.'s VRTX position evolved

VALLEY WEALTH MANAGERS, INC. first disclosed a stake in VRTX in Q3 2023 at 60,896 shares (US$21.2M). The position peaked in Q3 2026 at 51,753 shares, worth US$27.1M. Across 13 filings, VALLEY WEALTH MANAGERS, INC. increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 51,753 shares valued at US$27.1M — an increase of 424 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 60.90K $21.18M New
Q4 2023 59.30K $24.13M Reduce
Q1 2024 55.20K $23.08M Reduce
Q2 2024 51.48K $24.13M Reduce
Q3 2024 50.47K $23.47M Reduce
Q4 2024 50.52K $20.35M Hold
Q1 2025 49.48K $23.99M Reduce
Q2 2025 48.69K $21.68M Reduce
Q3 2025 49.82K $19.51M Add
Q4 2025 50.95K $23.10M Add
Q1 2026 50.14K $22.39M Reduce
Q2 2026 51.33K $25.50M Add
Q3 2026 51.75K $27.06M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VRTX and 13F data

VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VRTX

All VRTX fund holders →

FAQ

How long has VALLEY WEALTH MANAGERS, INC. held VRTX?

VALLEY WEALTH MANAGERS, INC. has disclosed VRTX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is VALLEY WEALTH MANAGERS, INC.'s current position in VRTX?

As of Q3 2026, VALLEY WEALTH MANAGERS, INC. holds 51.75K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $27.06M, representing 1.54% of its reported portfolio and ranking #24.

Has VALLEY WEALTH MANAGERS, INC. been buying or selling VRTX?

In the latest 13F filing (Q3 2026), VALLEY WEALTH MANAGERS, INC. increased its position in VRTX. The position peaked in Q3 2026 at 51.75K shares.

Which other funds hold VRTX?

Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.